CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving
Mathis.jpg
Dr. Diane Mathis obtained a Ph.D. from the University of Rochester, and performed postdoctoral studies at the Laboratoire de Génétique Moléculaire des Eucaryotes (LGME) in Strasbourg, France and at Stanford University Medical Center. She returned to France at the end of 1983, establishing a laboratory at the LGME [later the Institut de Genetique et de Biologie Moleculare et Cellulaire (IGBMC)] in Strasbourg, in conjunction with Dr. Christophe Benoist. The lab moved to the Joslin Diabetes Center, Boston, MA at the end of 1999. Through 2008, Dr. Mathis was a Professor of Medicine at Brigham and Women’s Hospital and Harvard Medical School, and an Associate Research Director and Head of the Section on Immunology and Immunogenetics at Joslin, where she held the William T. Young Chair in Diabetes Research. Dr. Mathis is currently Professor and Head of the Division of Immunology in the Department of Microbiology and Immunobiology at HMS, and holder of a Morton Grove-Rasmussen Chair in Immunohaematology. She is also a Principal Faculty Member at the Harvard Stem Cell Institute and an Associate Faculty Member of the Broad Institute. She presently serves on Scientific Advisory Boards of the Howard Hughes Medical Institute, Genentech, Fidelity Biosciences, and MedImmune, as well as of several research institutes worldwide. She is co-founder of Tempero, a biotech start-up that aims to produce novel therapeutics in the autoimmunity/inflammation space. Dr. Mathis was elected to the US National Academy of Sciences in 2003, the German Academy in 2007, and the American Academy of Arts and Sciences in 2012. The lab works in the fields of T cell differentiation and autoimmunity.

Interviewer: Richard Sever